Apyx Medical Corporation

NASDAQ:APYX

Medical - Devices

Healthcare
$2.49 -1.90%

-$0.08 today

Market cap
$104.89M
Beta
1.39
P/E (TTM)
-19.0
EPS (TTM)
-$0.22
52W Low $1.59High $5.08

Volume 0.19M

Average 0.18M

APYX Inventory

Raw materials, work in progress, and finished goods held for sale.

Apyx Medical CorporationNASDAQ: APYX

Inventory · Q1 FY2026 · quarter ended Mar 2026

Inventory rises 24.1% from a year ago

Inventory stood at $9.54M at the end of Q1 FY2026, up 24.1% from a year earlier and up 10.9% from the prior quarter. Over 3 fiscal years it compounded at -10.0% a year.

Context

  • Inventory amounted to 15.1% of total assets at the end of Q1 FY2026, up 2.4 pp from a year earlier.
  • Inventory increased in 1 of the last 3 fiscal years.

What to watch

Whether inventory keeps rising in the next quarterly balance sheet after a +24.1% change from a year earlier.

Sources:Balance SheetText generated from reported figures; not investment advice.

Latest quarterMar 2026
$9.54M+10.9% QoQ
Last fiscal yearDec 2025
$8.6M+13.7% YoY
Year agoMar 2025
$7.69M+24.1% since
Inventory past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+24.1%——
1 year+13.7%——
3-year CAGR-10.0%——
5-year CAGR——
10-year CAGR——

Inventory history

USD · from the balance sheet

Latest · FY2025
8.6M USD
Year-over-year change
+13.7%
4-year CAGR
+6.1%

Inventory vs competitors

How APYX compares with its peers on the latest reported figures

  • APYX's Mar 2026 inventory of $9.54M is the 4th highest of the 8 companies compared; the peer median is $6.12M.
  • Its year-over-year change of +24.1% is the 2nd highest of 6, against a peer median of -15.8%.
  • Inventory amounts to 15.1% of total assets for APYX, versus a peer median of 11.9%.
APYX Competitors Peer median
Inventory for APYX and competitors
Company Period Latest balance YoY 3-year CAGR% of assets
XTNTXtant Medical Holdings, Inc.Mar 2026$31.88M -17.9%+20.5%40.9%
PDEXPro-Dex, Inc.Mar 2026$22.36M -4.6%+20.6%29.8%
RPIDRapid Micro Biosystems, Inc.Mar 2026$17.45M -15.8%-6.0%28.0%
APYXApyx Medical CorporationMar 2026$9.54M +24.1%-10.0%15.1%
RCELAVITA Medical, Inc.Mar 2026$6.12M -27.1%+48.3%11.9%
LUCDLucid Diagnostics Inc.Mar 2026$1M +106.8%+47.1%2.9%
VANIVivani Medical, Inc.Mar 2026$0 ——0.0%
SERASera Prognostics, Inc.Mar 2026$0 ——0.0%
Peer median (excluding APYX) $6.12M-15.8%+20.6%11.9%

Competitors are the stored peer set for APYX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Balance Sheet

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents30.87M10.19M43.65M31.74M31.74M
Short-term Investments00000
Net Receivables21.16M18.25M14.02M15.48M16.78M
Inventory6.78M11.8M9.92M7.56M8.6M
Other Current Assets02.74M2.76M1.66M1.35M
Total Current Assets60.74M42.97M70.36M56.44M58.47M
Property, Plant & Equipment (Net)6.87M7.59M7.15M6.74M6.62M
Goodwill00000
Intangible Assets00000
Long-term Investments00000
Tax Assets00000
Other Non-current Assets1.11M1.22M1.73M1.66M1.75M
Total Non-current Assets7.98M8.8M8.88M8.4M8.37M
Total Assets68.72M51.78M79.24M64.84M66.84M
Account Payables2.63M2.67M2.71M2.62M3.06M
Short-term Debt000355K428K
Tax Payables2.29M2.08M000
Deferred Revenue533K853K488K693K0
Other Current Liabilities2.12M01.55M5.08M8.21M
Total Current Liabilities13.21M11.85M12.74M10.72M11.7M
Long-term Debt0033.19M33.89M34.85M
Deferred Tax Liabilities00000
Deferred Revenue (Non-current)1.32M1.41M1.25M1.12M1.05M
Other Non-current Liabilities166K181K198K259K347K
Total Non-current Liabilities1.51M2.13M39.58M39.79M40.31M
Total Liabilities14.71M13.98M52.32M50.51M52.01M
Common Stock34K35K35K38K42K
Retained Earnings(12.55M)(35.74M)(54.45M)(77.91M)(89.12M)
Accumulated OCI00000
Other Stockholders Equity00000
Minority Interest305K211K221K125K291K
Total Equity54.01M37.79M26.92M14.34M14.83M
Total Debt305K796K38.5M38.76M39.34M
Net Debt(30.57M)(9.4M)(5.15M)7.02M7.6M

Apyx Medical Corporation

NASDAQ:APYX

Intrinsic Alpha fair value

Locked

Current Price

$2.49

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.